Arrowhead Pharmaceuticals (ARWR) net assets (shareholders' equity)

Net assets · fiscal 2026
$50.31M

Arrowhead Pharmaceuticals (ARWR) had net assets of $50.31M at the end of fiscal 2026 (September 30, 2026). That is 89.2% lower than the $466.05M of fiscal 2025. Figures as of 19 Nov 2026, 00:22 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2026
$50.31M
Change on fiscal 2025
−89.2%
Growth, 5 years
−34.2% a year
Growth, 10 years
−6.2% a year
Highest on record
$466.05Mfiscal 2025
Lowest on record
$1.42Mfiscal 2003
Fiscal years on record
242003–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arrowhead Pharmaceuticals net assets (shareholders' equity), in more detail

Over the five fiscal years to 2026 net assets shrank at a compound 34.2% a year; over ten years the rate was −6.2% a year. Across the 24 fiscal years on record (2003–2026), the highest was $466.05M in fiscal 2025 and the lowest $1.42M in fiscal 2003.

History · 24 fiscal years

Net assets by fiscal year

Arrowhead Pharmaceuticals net assets (shareholders' equity), year by year

Arrowhead Pharmaceuticals (ARWR) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2026$50.31M 89.2% down
2025$466.05M 151.3% up
2024$185.44M 31.7% down
2023$271.34M 31.9% down
2022$398.52M 2.5% down
2021$408.82M 11.5% down
2020$461.78M 88.8% up
2019$244.59M 155.3% up
2018$95.80M 17.7% up
2017$81.42M 14.8% down
2016$95.58M 13.2% down
2015$110.18M 33.8% down
2014$166.54M 505.6% up
2013$27.50M 174.6% up
2012$10.01M 21.7% down
2011$12.79M 41.4% up
2010$9.05M 86.2% up
2009$4.86M 60.5% down
2008$12.30M 53.5% down
2007$26.46M 16.3% down
2006$31.61M 12.8% up
2005$28.03M 149.6% up
2004$11.23M 690.8% up
2003$1.42M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Arrowhead Pharmaceuticals and comparable companies
CompanyNet assetsFiscal year
Axsome Therapeutics AXSM$88.30M2025
Chemed CHE$979.41M2025
Oruka Therapeutics ORKA$471.93M2025
Arrowhead Pharmaceuticals ARWR$50.31M2026
MSA Safety MSA$1.37B2025
CG Oncology CGON$752.60M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ARWR

Arrowhead Pharmaceuticals, figure by figure

Arrowhead Pharmaceuticals (ARWR) overview: price, valuation and scorecardAll health care companies by market value

Arrowhead Pharmaceuticals net assets (shareholders' equity): questions and answers

What are Arrowhead Pharmaceuticals's net assets?

Arrowhead Pharmaceuticals (ARWR) had net assets of $50.31M at the end of fiscal 2026 (September 30, 2026). That is 89.2% lower than the $466.05M of fiscal 2025.

What is the growth rate of Arrowhead Pharmaceuticals's net assets?

Over the five fiscal years to 2026 net assets shrank at a compound 34.2% a year; over ten years the rate was −6.2% a year.

What are the highest and lowest net assets figures on record for Arrowhead Pharmaceuticals?

Across the 24 fiscal years on record (2003–2026), the highest was $466.05M in fiscal 2025 and the lowest $1.42M in fiscal 2003.

How is Arrowhead Pharmaceuticals's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Arrowhead Pharmaceuticals it is on record here for 24 fiscal years, 2003 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arrowhead Pharmaceuticals (ARWR) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/ARWR/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.